SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
I own quite a bit of this company, so naturally I view it as a company to own. I was kind of surprised that it had not been mentioned before. I would like to know if anyone has an interest in the stock, or perhaps knows something I do not. Thank You.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10280I hadn't posted the actual link, but should have. This is it: phx.corporatRocky9-9/27/2009
10279Thanks for posting the link to the 14D-9. Very interesting read, indeed. ShoulBiotech Jim-9/26/2009
10278Read the Sch 14D-9 last night. Very interesting story about the history of mergRocky9-9/25/2009
102777:27 AM ET Sepracor Raised To Neutral From Sell By Goldman Sachs Way to be on tsjemmeri29/4/2009
10276Thanks, Ken. That's the press release I mentioned. That call was over 9 hoJohn Metcalf-9/3/2009
10275Quote: "Conference Call Information DSP will host an investors meeting in kenhott19/3/2009
10274Dainippon and Sepracor had a joint conference call this morning at 6 EDT. Did aJohn Metcalf-9/3/2009
10273Sepracor Rises on Reported Sale to Dainippon for $2.7 Billion By Tom Randall sim1-9/2/2009
10272UPDATE 1-Dainippon Sumitomo to bid for Sepracor - Nikkei Wed Sep 2, 2009 1:53pm sim1-9/2/2009
10271Sepracor slides on trial failure and Lunesta halt Sepracor says FDA stopped 2 Lutnsaf-7/2/2009
10270Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once DailyIcebrg-6/29/2009
10269Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzalrkrw-6/24/2009
10268>>if so, 60 days are about up.>> MARLBOROUGH, Mass.--(BUSINESS WIREIcebrg-6/1/2009
10267Why is SEPR trading at this valuation......short interest in latest period droppArthur Radley-5/31/2009
10266>>Sepracor Announces Final Settlement of XOPENEX Inhalation Solution Patentuck-3/10/2009
10265I would agree that the market expectations were not significant for this indicatBiotech Jim-3/6/2009
10264>>Sepracor Reports Preliminary Phase II Study Results for SEP-225441 for ttuck-3/5/2009
10263I had the same thought (sale). But it is also reasonable that they are working John Metcalf-2/17/2009
10262Ah ok. Didn't know the notes had a put option! Now it makes sense. Wonder ifrkrw-2/17/2009
10261"Anyone with any guesses why they would be buying these back? " The 2John Metcalf12/17/2009
10260OK. So half life is a bit shorter. When all is said and done, i don't think rkrw-2/17/2009
10259Terrible taste but lower next-day hangover effects for the isomer...idos-2/17/2009
10258By the time a trial ended it may well end up in 2012 anyway. Plus appeals. How mrkrw-2/17/2009
10257Exactly when it was expected as W-H exclusivity expired mid Dec. Patents are runidos12/17/2009
10256Sepracor's Lunesta targeted by genericsBoston Business Journal - by Craig M.rkrw-2/16/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News